Advertisement

Index by author

November 01, 1995; Volume 23,Issue 11

A

  1. Anderson, C D

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

B

  1. Baba, T

    1. In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;

  2. Barton, H A

    1. Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;

  3. Beauchamp, L

    1. Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;

  4. Binkley, S N

    1. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;

  5. Boado, R J

    1. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;

  6. Boehlert, C C

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  7. Bonfils, C

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

  8. Bozler, G

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

  9. Brashear, W T

    1. Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;

  10. Brien, J F

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

  11. Buhler, D R

    1. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
      W G Chung and D R Buhler
      Drug Metabolism and Disposition November 1995, 23 (11) 1263-1267;

  12. Burke, M D

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

  13. Busch, U

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

C

  1. Cho, Y B

    1. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;

  2. Choudhuri, S

    1. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;

  3. Chung, W G

    1. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
      W G Chung and D R Buhler
      Drug Metabolism and Disposition November 1995, 23 (11) 1263-1267;

  4. Colthup, P V

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

D

  1. de Miranda, P

    1. Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;

  2. Dixon, C M

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  3. Domergue, J

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

E

  1. Ekins, S

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

F

  1. Fujita, S

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

G

  1. Gillet, G

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

H

  1. Hall, T W

    1. Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;

  2. Hawksworth, G M

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

  3. Heinzel, G

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

  4. Higuchi, S

    1. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;

  5. Hoshi, H

    1. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

I

  1. Ichimura, F

    1. Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

J

  1. Jimmo, S L

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

K

  1. Kang, Y S

    1. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;

  2. Kaschke, S

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

  3. Kazusaka, A

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

  4. Kerr, B M

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  5. Kim, D K

    1. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;

  6. Kim, K H

    1. Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;

  7. Krasny, H C

    1. Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;

  8. Krenitsky, T A

    1. Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;

  9. Kumar, G N

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

  10. Kummer, M

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

L

  1. Lipscomb, J C

    1. Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;

M

  1. Mahle, D A

    1. Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;

  2. Marchant, N C

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

  3. Marks, G S

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

  4. Masuda, M

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

  5. Matsubara, T

    1. In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;

  6. Matsushita, R

    1. Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

  7. Maurel, P

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

  8. McLaughlin, B E

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

  9. McMillan, J M

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

  10. Murray, G I

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

N

  1. Nakamura, A

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;

  2. Nakashima, E

    1. Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

  3. Nakatsu, K

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

O

  1. Ohshima, T

    1. Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

  2. Ortiz de Montellano, P R

    1. The 1994 Bernard B. Brodie Award Lecture. Structure, mechanism, and inhibition of cytochrome P450.
      P R Ortiz de Montellano
      Drug Metabolism and Disposition November 1995, 23 (11) 1181-1187;

P

  1. Pardridge, W M

    1. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;

  2. Park, G R

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  3. Pichard, L

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

  4. Poklewska-Koziell, M

    1. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

S

  1. Schmid, J

    1. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

  2. Serabjit-Singh, C J

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  3. Sharer, J E

    1. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;

  4. Shipley, L A

    1. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;

  5. Sugimoto, C

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;

  6. Suimamoto, Y

    1. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

T

  1. Tarbit, M H

    1. Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

  2. Tasaki, T

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;

  3. Taylor, W G

    1. Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;

  4. Thénot, J P

    1. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

  5. Thomas, P E

    1. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;

  6. Touchi, A

    1. In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;

  7. Tsuji, A

    1. Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

U

  1. Usui, T

    1. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;

V

  1. Vandenbranden, M R

    1. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;

  2. Vanderbeck, S M

    1. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;

  3. Vedres, D D

    1. Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;

W

  1. Walle, T

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

  2. Walle, U K

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

  3. Wang, J

    1. Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

  4. Waskiewicz, M J

    1. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;

  5. Watanabe, T

    1. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;

  6. Williams, J A

    1. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

  7. Wrighton, S A

    1. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;

  8. Wu, D

    1. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;

Y

  1. Yamaguchi, Y

    1. In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;

  2. Yamamoto, Y

    1. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

Z

  1. Zhang, X J

    1. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
Back to top

In this issue

Advertisement